FindTrial
Sign In

Stromal vascular fraction assisted autologous fat transplantation for breast augmentation: A randomized, double blind, self controlled prospective clinical study.

Application of stromal vascular fraction combined withautologous fat in soft tissue defect.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17011967
Enrollment
Unknown
Registered
2017-07-13
Start date
2017-07-15
Completion date
Unknown
Last updated
2017-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

soft tissue defect

Interventions

Control Group:autologous fat transplantation for breast augmentation
Experience Group:stromal vascular fraction assisted autologous fat transplantation for breast augmentation

Sponsors

Guangdong Second Provincial General Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. female aged 18-40 years old; 2. breast smaller and bilateral breast size and shape symmetry; 3. breast BI-RADS score of 2 or less; 4. the BMI index (body mass index) 18.5-28; 5. volunteered to participate in this clinical study.

Exclusion criteria

Exclusion criteria: 1. breast inflammation, skin infection is unfavorable for fat breast augmentation; 2. breast cancer history or breast resection; 3. endocrine diseases, such as hyperthyroidism; 4. infectious diseases such as AIDS, hepatitis B, etc.; 5. heart, lung, liver, kidney and other organic lesions; 6. narcotic drug allergy; 7. abnormal coagulation function; 8. other surgical disease can not be tolerated; 9. breast BI-RADS score > 2; 10. BMI index (BMI) higher than 28 or less than 18.5.

Design outcomes

Primary

MeasureTime frame
Fat volume;Fat volume;Fat volume;Fat volume;Fat volume;Fat Volume;—

Secondary

MeasureTime frame
Benign breast disease;Malignant breast disease;—

Countries

China

Contacts

Public ContactLuo Shengkang

Guangdong Second Provincial General Hospital

luoshengkang63@hotmail.com+86 020-89168073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026